Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00546026|
Recruitment Status : Unknown
Verified October 2007 by Mount Sinai Hospital, Canada.
Recruitment status was: Not yet recruiting
First Posted : October 18, 2007
Last Update Posted : October 18, 2007
|Condition or disease||Intervention/treatment||Phase|
|High-Risk Pregnancy||Other: placental function assessment||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||160 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Does Mid-Gestation Placental Function Assessment Reduce Psychological Distress in Women With High-Risk Pregnancies?|
Active Comparator: Active group
Receive assessment of placental function
Other: placental function assessment
Formal assessment of placental function in mid-gestation by placental morphology and uterine artery Doppler at 20-22 weeks and re-interpretation of prior biochemical tests for Down's syndrome and spina bifida.
- Primary outcome measure is STAI - The State Trait Anxiety Inventory [ Time Frame: Cross-sectional ]
- Women who undergo the placental function assessment will deliver at a later gestation age, have less complications and stillbirths than untested women. Neonates will have higher APGAR scores at 1 and 5 minutes and less likely to be admitted to the NICU. [ Time Frame: Cross-sectional ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00546026
|Contact: Eileen P. Sloan, MD||416-586-4800 ext firstname.lastname@example.org|
|Contact: Barbara Field||416-586-4800 ext email@example.com|
|Mount Sinai Hospital||Not yet recruiting|
|Toronto, Ontario, Canada, M5G 1X5|
|Principal Investigator: Eileen P. Sloan, MD|
|Sub-Investigator: Cynthia Maxwell, MD|
|Sub-Investigator: William J. Lancee, Ph.D.|
|Sub-Investigator: John C. Kingdom, MD|
|Principal Investigator:||Eileen P. Sloan, MD||Mount Sinai Hospital, Canada|